Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
With compounding access limited, some patients have turned to gray-market peptide suppliers
A short list of peptides is legally available to buy online today through licensed telehealth companies working with 503A and 503B compounding pharmacies, while a larger list is moving through a formal FDA review that will decide whether more come back
How to Dose (the Research Protocol) The dosing below reflects the documented starting protocol on our own product pages
US$ 21.14
US$ 27.80
US$ 27.99